Insider Transactions in Q1 2023 at Aurinia Pharmaceuticals Inc. (AUPH)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 02
2023
|
George M Milne Jr Director |
BUY
Open market or private purchase
|
Direct |
20,000
+22.22%
|
$160,000
$8.91 P/Share
|
|
Mar 02
2023
|
Peter Greenleaf Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
32,750
-3.22%
|
$262,000
$8.94 P/Share
|
|
Mar 02
2023
|
Peter Greenleaf Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
667,407
+39.65%
|
-
|
|
Mar 02
2023
|
Volker Knappertz EVP, Research and Development |
BUY
Grant, award, or other acquisition
|
Direct |
191,462
+35.74%
|
-
|
|
Mar 02
2023
|
Scott Michael Habig Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
170,188
+35.24%
|
-
|
|
Mar 02
2023
|
Michael Robert Martin Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
107,202
+29.26%
|
-
|
|
Mar 02
2023
|
Stephen P. Robertson EVP, General Counsel |
SELL
Open market or private sale
|
Direct |
19,402
-6.01%
|
$155,216
$8.94 P/Share
|
|
Mar 02
2023
|
Stephen P. Robertson EVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
204,810
+38.82%
|
-
|
|
Mar 02
2023
|
Joseph M Miller Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11,296
-3.3%
|
$90,368
$8.94 P/Share
|
|
Mar 02
2023
|
Joseph M Miller Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
229,421
+40.11%
|
-
|
|
Mar 02
2023
|
Matthew Maxwell Donley EVP, Ops & Strategy |
BUY
Grant, award, or other acquisition
|
Direct |
271,134
+40.21%
|
-
|